BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 35242214)

  • 1. Glycine Decarboxylase (GLDC) Plays a Crucial Role in Regulating Energy Metabolism, Invasion, Metastasis and Immune Escape for Prostate Cancer.
    Chen MK; Xiao ZY; Huang ZP; Xue KY; Xia H; Zhou JW; Liao DY; Liang ZJ; Xie X; Wei QZ; Zhong L; Yang JK; Liu CD; Liu Y; Zhao SC
    Int J Biol Sci; 2023; 19(15):4726-4743. PubMed ID: 37781511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLIS1, Correlated with Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer.
    Peng Q; Xie T; Wang Y; Ho VW; Teoh JY; Chiu PK; Ng CF
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells.
    Cascardo F; Anselmino N; Páez A; Labanca E; Sanchis P; Antico-Arciuch V; Navone N; Gueron G; Vázquez E; Cotignola J
    Antioxidants (Basel); 2021 Jun; 10(6):. PubMed ID: 34208670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Signature Genes and Construction of an Artificial Neural Network Model of Prostate Cancer.
    Dong H; Wang X
    J Healthc Eng; 2022; 2022():1562511. PubMed ID: 35432828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.
    Li JD; Chen Y; Jing SW; Wang LT; Zhou YH; Liu ZS; Song C; Li DZ; Wang HQ; Huang ZG; Dang YW; Chen G; Luo JY
    Eur J Med Res; 2023 Dec; 28(1):591. PubMed ID: 38102653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of
    Yang X; Li J; Hu X; Zhang Y; Kuang Y; Liu Y; Liu C; Gao H; Ma L; Tang J; Ma Q
    Front Cardiovasc Med; 2022; 9():993579. PubMed ID: 36561770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer.
    Choi SYC; Ribeiro CF; Wang Y; Loda M; Plymate SR; Uo T
    Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of the Role of
    Chu M; Zheng K; Li X; Luo Z; Yang X; Wei C
    Anal Cell Pathol (Amst); 2022; 2022():2371057. PubMed ID: 36247875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy.
    Liu Z; Zhong J; Zeng J; Duan X; Lu J; Sun X; Liu Q; Liang Y; Lin Z; Zhong W; Wu W; Cai C; Zeng G
    Front Immunol; 2021; 12():735170. PubMed ID: 34531875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of Glycolytic Regulator Gene Signature to Predict the Prognosis and Tumor Immune Cell Infiltration Levels for Prostate Cancer.
    Zhang L; Wang B; Wang ZS; Guo YL; Shen H
    Comput Math Methods Med; 2022; 2022():9273559. PubMed ID: 35242214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Expression Analysis Reveals Key Genes and Signalings Associated with the Prognosis of Prostate Cancer.
    Shen H; Guo YL; Li GH; Zhao W; Zhang L
    Comput Math Methods Med; 2021; 2021():9946015. PubMed ID: 34497666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker.
    Wang L; Liu X; Liu Z; Wang Y; Fan M; Yin J; Zhang Y; Ma Y; Luo J; Li R; Zhao X; Zhang P; Zhao L; Fan J; Chen Y; Lu W; Song X
    Sci Rep; 2022 Jan; 12(1):192. PubMed ID: 34996995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
    Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
    Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer.
    Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L
    Front Immunol; 2022; 13():777724. PubMed ID: 35154101
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.